SCHEMBL5623918

SCHEMBL5623918

C=CCNc1cc2c(c3ccccc13)C(CCl)CN2C(=O)C=Cc1ccc(OC)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
GAA P10253 3/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
ADH1A P07327 1/20 0.40
KIT P10721 1/20 0.40
FLT1 P17948 1/20 0.40
FLT4 P35916 1/20 0.40
KDR P35968 1/20 0.40
ABL2 P42684 1/20 0.40
MAPT P10636 2/20 0.39
KMT2A Q03164 1/20 0.38
GPR183 P32249 3/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
APP P05067 1/20 0.36
GSK3B P49841 1/20 0.36
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5623910 1.00 ALDH1A1 (0.41) ALDH1A1GAALMNAHPGDADH1A
SCHEMBL21366179 0.87 ALDH1A1 (0.44) ALDH1A1GAALMNAHPGDADH1A
SCHEMBL14499189 0.85 ALDH1A1 (0.47) ALDH1A1GAALMNAHPGDADH1A
SCHEMBL6204431 0.84 ALDH1A1 (0.40) ALDH1A1GAALMNAHPGDADH1A
SCHEMBL6204423 0.84 ALDH1A1 (0.40) ALDH1A1GAALMNAHPGDADH1A
SCHEMBL74903 0.84 ALDH1A1 (0.46) ALDH1A1GAALMNAHPGDADH1A
SCHEMBL26322204 0.84 ALDH1A1 (0.46) ALDH1A1GAALMNAHPGDADH1A
SCHEMBL74904 0.84 ALDH1A1 (0.46) ALDH1A1GAALMNAHPGDADH1A
SCHEMBL18378477 0.80 ALDH1A1 (0.42) ALDH1A1GAALMNAHPGDADH1A
SCHEMBL18308252 0.80 ALDH1A1 (0.42) ALDH1A1GAALMNAHPGDADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7235578-B2 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3H-[ring fused indol-5-yl-(amine-derived)] compounds and analogues thereof, and to products obtained therefrom AUCKLAND UNISERVICES LIMITED (NZ) 2007-06-26 US claimed
US-20050148651-A1 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl-(amine- derived)] compounds and analogues thereof, and to products obtained therefrom AUCKLAND UNISERVICES LIMITED (NZ) 2005-07-07 US claimed
WO-2003097635-A1 PROCESSES FOR PREPARING 3-SUBSTITUTED 1-(CHLOROMETHYL)-1,2-DIHYDRO-3H-[RING FUSED INDOL-5-YL(AMINE-DERIVED)] COMPOUNDS AND ANALOGUES THEREOF, AND TO PRODUCTS OBTAINED THEREFROM AUCKLAND UNISERVICES LIMITED (NZ) 2003-11-27 WO claimed
US-7235578-B2 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3H-[ring fused indol-5-yl-(amine-derived)] compounds and analogues thereof, and to products obtained therefrom AUCKLAND UNISERVICES LIMITED (NZ) 2007-06-26 US disclosed
US-20050148651-A1 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl-(amine- derived)] compounds and analogues thereof, and to products obtained therefrom AUCKLAND UNISERVICES LIMITED (NZ) 2005-07-07 US disclosed
WO-2003097635-A1 PROCESSES FOR PREPARING 3-SUBSTITUTED 1-(CHLOROMETHYL)-1,2-DIHYDRO-3H-[RING FUSED INDOL-5-YL(AMINE-DERIVED)] COMPOUNDS AND ANALOGUES THEREOF, AND TO PRODUCTS OBTAINED THEREFROM AUCKLAND UNISERVICES LIMITED (NZ) 2003-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148651-A1 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl-(amine- derived)] compounds and analogues thereof, and to products obtained therefrom CBR3, ANPEP, CBR1 ALDH1A1 437/4885GAA 641/4885LMNA 4679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.